Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells

Published:2019 Issue:9 Volume:1 Page:3626-3638
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Avvakumova S.¹²³⁴,Pandolfi L.⁵⁶⁷⁴,Soprano E.¹²³⁴,Moretto L.¹²³⁴,Bellini M.¹²³⁴,Galbiati E.¹²³⁴,Rizzuto M. A.¹²³⁴,Colombo M.¹²³⁴,Allevi R.⁸⁹¹⁰⁴,Corsi F.⁸⁹¹⁰⁴¹¹,Sánchez Iglesias A.¹²¹³¹⁴¹⁵,Prosperi D.¹²³⁴¹⁶^ORCID

Affiliation:

1. University of Milano-Bicocca

2. Department of Biotechnology and Bioscience

3. Milano

4. Italy

5. Clinica di Malattie dell’Apparato Respiratorio

6. IRCCS Fondazione Policlinico San Matteo

7. Pavia

8. Dipartimento di Scienze Biomediche e Cliniche “Luigi Sacco”

9. Università di Milano

10. 20157 Milano

11. Surgery Department

12. Bionanoplasmonics Laboratory

13. CICbiomaGUNE

14. 20014 Donostia-San Sebastián

15. Spain

16. Nanomedicine Laboratory

Abstract

The efficient targeting of cancer cells depends on the success of obtaining the active targeting of overexpressed receptors.

Funder

Fondazione per la Ricerca Biomedica

Seventh Framework Programme

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Materials Science,General Chemistry,Atomic and Molecular Physics, and Optics,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2019/NA/C9NA00241C

Reference61 articles.

1. Current Challenges in Cancer Treatment

2. Particle therapy and nanomedicine: state of art and research perspectives

3. Recent trends of nanomedicinal approaches in clinics

4. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics

5. Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A holistic review of recent advances in nano-based drug delivery systems for the treatment of triple-negative breast cancer (TNBC);Journal of Nanoparticle Research;2024-05

2. Coiled-Coil-Based Biofunctionalization of 100 nm Gold Nanoparticles with the Trastuzumab Antibody for the Detection of HER2-Positive Cancer Cells;Langmuir;2023-08-15

3. Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?;Expert Opinion on Therapeutic Targets;2023-05-04

4. Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona “variable”;Nanoscale Advances;2023

5. Microfluidic SERS devices: brightening the future of bioanalysis;Discover Materials;2022-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3